In spite of the variability of public policy toward drugs, relatively
little attention has been devoted to providing positive explanations o
f drug legislation or to identifying economic interests which have ben
efited from such restrictions. With their general aim being to conside
r the motivating factors behind variability in drug policy, the author
s estimate econometric models of U.S. senatorial support for prohibiti
on in 1917 and for repeal in 1933. Their results indicate that while t
he commonly cited influence of public opinion clearly mattered, the sy
stematic influence of the brewing/distilling industries and possibly u
nderground suppliers can be detected in these votes.